Recently we and other groups identified serum KL-6 as a novel biomarker of COVID-19 severity (21, 28), here we also determined the KL-6 level of severe patients on admission and found it was similar in MP and non-MP groups (420.9 vs 407.8 U/mL, p=1.000). The gene discussed is MUC1; the disease is COVID-19.